Research Article
Symptoms and Severity of COVID-19 in Patients with Immune-Mediated Inflammatory Diseases: Experience of a University Medical Center
Table 1
Patient distribution of rheumatic and inflammatory bowel diseases.
| Characteristic | No. | % |
| Total | 156 | 100 | Inflammatory bowel disease | 117 | 75.0 | Crohn’s disease | 69 | 44.2 | Ulcerative colitis | 48 | 30.8 | Rheumatic disease | 39 | 25.0 | Rheumatoid arthritis | 13 | 8.3 | Axial spondyloarthritis | 9 | 5.8 | Systemic lupus erythematosus | 6 | 3.8 | Psoriatic arthritis | 6 | 3.8 | Granulomatosis with polyangiitis | 2 | 1.3 | Sjögren’s syndrome | 1 | 0.6 | Juvenile idiopathic arthritis | 1 | 0.6 | Dermatomyositis/polymyositis | 1 | 0.6 |
|
|